Latest Leverage News

DY6 Metals has confirmed high-grade titanium dioxide levels in rutile samples from its Central Rutile Project in Cameroon, supporting the calibration of a portable XRF analyser for real-time exploration.

Cash Converters has expanded its Australian footprint by acquiring 14 franchise stores across key states, reinforcing its strategy to grow earnings and consumer lending.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

Metro Performance Glass is set to strengthen its balance sheet and support its turnaround strategy through a $15 million to $24 million equity raise, with Amari Metals Australia poised to become the majority shareholder. This recapitalisation aims to reduce debt and improve operational focus amid challenging market conditions.

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.

X2M Connect Limited has completed a $309,000 entitlement offer by issuing 23.76 million new shares and options, while a substantial shortfall of nearly 127 million shares remains available for placement.

Rewardle Holdings Limited reported a 2.8% revenue increase to $9.68 million for FY24 but swung to a $3.44 million net loss, driven by rising expenses and associate losses. The company expanded its footprint with acquisitions in grocery delivery and fintech, while deepening its stake in AI-powered health tech partner CloudHolter.

Magnetite Mines Limited has updated its Razorback Iron Ore Project, revealing a 6.6 billion tonne mineral resource and progressing key strategic partnerships and approvals to support green steelmaking ambitions.

Elders Limited faces a regulatory delay from the ACCC on its acquisition of Delta Agribusiness but remains optimistic about the deal's benefits and completion timeline.

PYC Therapeutics has escalated dosing to the highest level in its Phase 1a trial of PYC-003 and begun dosing patients with Polycystic Kidney Disease, marking key progress toward regulatory milestones.

5E Advanced Materials has released a robust Preliminary Feasibility Study for its Fort Cady Project in California, highlighting a 39.5-year mine life and strong economics with a pre-tax NPV7 of US$724.8 million and a 19.2% IRR.